Wells Fargo Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Cuts Target Price to $12
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Staar Surgical (STAA) and Hyperfine (HYPR)
Wedbush Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Cuts Target Price to $9
Wedbush Adjusts Price Target on Voyager Therapeutics to $9 From $11, Maintains Outperform Rating
Voyager Therapeutics: Buy Rating Affirmed Amidst Promising Alzheimer's Program and Strong Financial Health
Voyager Therapeutics Analyst Ratings
H.C. Wainwright Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $30
Oppenheimer Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $18
Cantor Fitzgerald Initiates Voyager Therapeutics(VYGR.US) With Buy Rating
Voyager Therapeutics Analyst Ratings
Citigroup Initiates Coverage On Voyager Therapeutics With Buy Rating, Announces Price Target of $12
Citi Initiates Voyager Therapeutics(VYGR.US) With Buy Rating, Announces Target Price $12
Wedbush Upgrades Voyager Therapeutics(VYGR.US) to Buy Rating, Announces Target Price $11
Analysts Are Bullish on Top Healthcare Stocks: Voyager Therapeutics (VYGR), BioNTech SE (BNTX)
A Quick Look at Today's Ratings for Voyager Therapeutics(VYGR.US), With a Forecast Between $14 to $30
Truist Financial Maintains Voyager Therapeutics(VYGR.US) With Buy Rating
Analysts Conflicted on These Healthcare Names: McKesson (MCK), Fate Therapeutics (FATE) and Voyager Therapeutics (VYGR)
Wells Fargo Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $14
TD Cowen Maintains Voyager Therapeutics(VYGR.US) With Buy Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Voyager Therapeutics (VYGR), Align Tech (ALGN) and Cigna (CI)